Registered number:
03222950
GNOSALL HEALTH CARE LIMITED
UNAUDITED
DIRECTORS' REPORT AND FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2019
|
GNOSALL HEALTH CARE LIMITED
COMPANY INFORMATION
|
GNOSALL HEALTH CARE LIMITED
CONTENTS
|
|
|
|
|
|
|
|
Statement of changes in equity
|
|
Notes to the financial statements
|
|
|
GNOSALL HEALTH CARE LIMITED
DIRECTORS' REPORT
FOR THE PERIOD ENDED 31 MARCH 2019
The directors present their report and the financial statements for the period ended 31 March 2019 comparative 5 month period ended 31 March 2018.
The company ceased trading on 31 October 2017. On 1st November 2017 the entire issued share capital of the company was acquired by Day Lewis plc and trade and assets were hived up into that company.
The directors who served during the period were:
In preparing this report, the directors have taken advantage of the small companies exemptions provided by section 415A of the Companies Act 2006.
This report was approved by the board and signed on its behalf.
|
GNOSALL HEALTH CARE LIMITED
PROFIT AND LOSS ACCOUNT
FOR THE PERIOD ENDED 31 MARCH 2019
|
|
Period from 1 November 2017 to
31 March
|
|
|
|
|
|
|
|
|
|
|
Profit on hive up at fair value
|
|
|
|
|
|
|
|
|
|
|
|
Profit for the financial period
|
|
|
|
The Company has not traded during the period. During this period, the Company received no income and
incurred no expenditure other than exempted payments under the provisions of section 1169 (3)(b) of the
Companies Act 2006.
|
The notes on pages 5 to 7 form part of these financial statements.
|
|
GNOSALL HEALTH CARE LIMITED
REGISTERED NUMBER:
03222950
BALANCE SHEET
AS AT
31 MARCH 2019
|
|
|
|
|
|
|
|
|
|
|
|
Debtors: amounts falling due within one year
|
|
|
|
|
|
|
|
|
|
|
|
Total assets less current liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the period ended 31 March 2019 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.
Members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The Company's
financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved and authorised for issue by the board and were signed on its behalf on
12 December 2019
.
The notes on pages 5 to 7 form part of these financial statements.
|
GNOSALL HEALTH CARE LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED
31 MARCH 2019
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income for the period
|
|
|
|
Dividends: Equity capital
|
|
|
|
|
|
|
|
|
|
|
|
STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED
31 MARCH 2018
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income for the period
|
|
|
|
|
|
|
|
Total comprehensive income for the period
|
|
|
|
|
|
|
|
|
|
|
|
|
The notes on pages 5 to 7 form part of these financial statements.
|
|
GNOSALL HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2019
Gnosall Health Care Limited (the “Company”) is a private company limited by shares and incorporated, domiciled and registered in England in the United Kingdom. The address of the registered office is given on company information page.
2.
Accounting policies
|
|
Basis of preparation of financial statements
|
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in
the UK and the Republic of Ireland and the Companies Act 2006
.
The functional currency of Gnosall Health Care Limited is considered to be pounds sterling because that is the currency of the primary economic environment in which the Company operates. The financial statements are also presented in pounds sterling and rounded to nearest £.
The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the Company's accounting policies.
|
|
Financial reporting standard 102 - reduced disclosure exemptions
|
The company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
∙
the requirements of Section 4 Statement of Financial Position paragraph 4.12(a)(iv);
∙
the requirements of Section 7 Statement of Cash Flows;
∙
the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d);
∙
the requirements of Section 26 Share-based Payment paragraphs 26.18(b), 26.19 to 26.21 and 26.23;
∙
the requirements of Section 33 Related Party Disclosures paragraph 33.7.
This information is included in the consolidated financial statements of Day Lewis Plc as at 31 March 2019 and these financial statements may be obtained from 2 Peterwood Way, Croydon, CR0 4UQ.
As the directors do not intend to acquire a replacement trade, the directors have not prepared the financial statements on a going concern basis.
Turnover comprises revenue recognised by the Company in respect of goods and services supplied during the period, exclusive of Value Added Tax and trade discounts.
Exceptional items are transactions that fall within the ordinary activities of the Company but are presented separately due to their size or incidence.
|
GNOSALL HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2019
2.
Accounting policies (continued)
Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.
All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.
Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.
Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives.
Depreciation is provided on the following basis:
The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Profit and loss account.
Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.
|
The average monthly number of employees, including the directors, during the period was as follows:
|
|
|
|
|
Period from 1 November 2017 to
31 March
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmacists and sales assistants
|
|
|
|
GNOSALL HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2019
|
|
|
|
|
|
|
|
Period from 1 November 2017 to
31 March
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Profit on disposal of trade and assets
|
|
|
|
|
|
|
|
On 1st November 2017, after the acquisition of the company by Day Lewis plc, the trade and assets were hived up at fair value to that company.
|
|
|
|
|
|
Amounts owed by group undertakings
|
|
|
|
|
|
|
|
|
|
|
|
|
Allotted, called up and fully paid
|
|
|
|
|
|
|
|
|
|
48,004
(2018 -
48,004
)
Ordinary
shares of £
1.00
each
|
|
|
The company's immediate parent company is Day Lewis plc, a company registered in England and Wales. It prepares group accounts which are available at Day Lewis House, 2 Peterwood Way, Croydon, Surrey CR0 4UQ.
The ultimate parent company is Day Lewis Holdings Limited, a company registered in Cyprus and controlled by the Kirit Patel Will Trust.
Copies of the ultimate parent and of its group financial statements are not publicly available.
|
|